Officials from the Ministry of Health of Thailand met with the chairman of Shenzhen Cell Valley to discuss the layout of the cell therapy industry
On September 30,2024, at the invitation of the Thai government, Dr. Shi Genyuan, chairman of Shenzhen Cell Valley, led a delegation to Thailand and held high-level talks with officials of the Thai Health Service Department in the Thai Government Building. The talks aimed to promote the Shenzhen Cell Valley's cell therapy industry project in Thailand and explore in-depth cooperation with local governments, medical institutions and universities in the field of cell therapy.
Talks attended personnel include: Thailand health services vice minister samat, Dr Sark, medical industry promotion bureau deputy director Dr Mr Kui Sue, assisted reproductive technology experts, recuperation and treatment bureau leader, ms, his, Shenzhen cell valley chairman, chairman, chairman assistant FuYuchen Dr, and partner KunLingTai hospital group (Kluaynamthai Hospital Group) President, Dr New Cha, etc.
Talks attended personnel include: Thailand health services vice minister samat, Dr Sark, medical industry promotion bureau deputy director Dr Mr Kui Sue, assisted reproductive technology experts, recuperation and treatment bureau leader, ms, his, Shenzhen cell valley chairman, chairman, chairman assistant FuYuchen Dr, and partner KunLingTai hospital group (Kluaynamthai Hospital Group) President, Dr New Cha, etc.
During the meeting, Dr. Shi introduced in detail the leading advantages and market prospects of Shenzhen Cell Valley in cell therapy technology, and expressed his strong willingness to establish long-term strategic cooperation with medical institutions and academic institutions in Thailand. Dr. Samat is highly aware of the investment and technical cooperation of Shenzhen Cell Valley, and promises that the Thai government will provide comprehensive support and necessary policy facilitation for the smooth implementation of the project.
In addition, the two sides also had in-depth discussions on the introduction of Shenzhen Cell Valley to help Thailand to establish a regulatory system in accordance with international standards, especially the introduction of FACT (Cell Therapy Certification Foundation) and AABB (American Association for Blood and Biological Therapy) certification. This exchange has laid a solid foundation for the policy standardization of the Thai cell therapy industry. The two sides also had constructive discussions on bio-pharmaceutical research and development, clinical research cooperation and talent training.
The talks further deepened the mutual trust between Shenzhen Cell Valley and the Ministry of Health of Thailand, and laid a solid foundation for the future market expansion in Thailand. We sincerely thank the Thai government for its support and look forward to the two sides to reach a specific cooperation agreement as soon as possible to jointly promote the vigorous development of the cell therapy industry in Thailand.